Skip to content
PICO Portalanswers from OpenAlex

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance

PaperCitations, authors & open-access status

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is a paper indexed in PICO Portal from OpenAlex.

How many citations does Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance have?

PICO Portalcitation count

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance has 34 citations in the OpenAlex counts PICO Portal stores.

When was Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance published?

PICO Portalyear

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance has 2012 year in the PICO Portal index.

What is the open-access status of Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

PICO Portaloa status

Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance has closed oa status in the PICO Portal index.

What is the DOI of Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

PICO Portaldoi

The DOI for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is on the source record.

What is the PMID of Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

PICO Portalpmid

The PMID for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is on the source record.

What is the OpenAlex record for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance?

PICO Portalopenalex

The OpenAlex for Safety of the long-acting neuraminidase inhibitor laninamivir octanoate hydrate in post-marketing surveillance is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial